Artis David
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Rosenthal 207, 3800 Spruce Street, Philadelphia, PA 19104, USA.
Int J Parasitol. 2006 May 31;36(6):723-33. doi: 10.1016/j.ijpara.2006.02.011. Epub 2006 Mar 13.
Parasitic nematode infections of humans and livestock continue to impose a significant public health and economic burden worldwide. Murine models of intestinal nematode infection have proved to be relevant and tractable systems to define the cellular and molecular basis of how the host immune system regulates resistance and susceptibility to infection. While susceptibility to chronic infection is propagated by T helper cell type 1 cytokine responses (characterised by production of IL-12, IL-18 and interferon-gamma), immunity to intestinal-dwelling adult nematode worms is critically dependent on a type 2 cytokine response (controlled by CD4+T helper type 2 cells that secrete the cytokines IL-4, IL-5, IL-9 and IL-13). However, the immune effector mechanisms elicited by type 2 cytokines in the gut microenvironment that precipitate worm expulsion have remained elusive. This review focuses on new studies that implicate host intestinal epithelial cells as one of the dominant immune effector cells against this group of pathogens. Specifically, three recently identified type 2 cytokine-dependent pathways that could offer insights into the mechanisms of expulsion of parasitic nematodes will be discussed: (i) the intelectins, a new family of galactose-binding lectins implicated in innate immunity, (ii) the resistin-like molecules, a family of small cysteine-rich proteins expressed by multiple cell types, and (iii) cytokine regulation of intestinal epithelial cell turnover. Identifying how the mammalian immune response fights gastrointestinal nematode infections is providing new insights into host protective immunity. Harnessing these discoveries, coupled with identifying what the targets of these responses are within parasitic nematodes, offers promise in the design of a new generation of anti-parasitic drugs and vaccines.
人类和家畜的寄生线虫感染在全球范围内持续造成重大的公共卫生和经济负担。肠道线虫感染的小鼠模型已被证明是定义宿主免疫系统调节感染抗性和易感性的细胞和分子基础的相关且易于处理的系统。虽然对慢性感染的易感性由1型辅助性T细胞细胞因子反应(以白细胞介素-12、白细胞介素-18和干扰素-γ的产生为特征)传播,但对肠道内成年线虫的免疫关键依赖于2型细胞因子反应(由分泌细胞因子白细胞介素-4、白细胞介素-5、白细胞介素-9和白细胞介素-13的2型辅助性CD4 + T细胞控制)。然而,在肠道微环境中由2型细胞因子引发的促使蠕虫排出的免疫效应机制仍然难以捉摸。本综述重点关注新的研究,这些研究表明宿主肠道上皮细胞是针对这类病原体的主要免疫效应细胞之一。具体而言,将讨论最近确定的三种可能为寄生线虫排出机制提供见解的2型细胞因子依赖性途径:(i)凝集素,一个与先天免疫有关的新的半乳糖结合凝集素家族,(ii)抵抗素样分子,一类由多种细胞类型表达的富含半胱氨酸的小蛋白质家族,以及(iii)细胞因子对肠道上皮细胞更新的调节。确定哺乳动物免疫反应如何对抗胃肠道线虫感染正在为宿主保护性免疫提供新的见解。利用这些发现,再加上确定这些反应在寄生线虫中的靶点,有望设计出新一代的抗寄生虫药物和疫苗。